Integral Diagnostics trials AI imaging tools ahead of a national lung cancer screening rollout as healthcare names outperform the market.
Why Is Integral Diagnostics (ASX:IDX) in Focus?
Integral Diagnostics trials AI imaging tools ahead of a national lung cancer screening rollout as healthcare names outperform the market.